Stefan Duensing
Affiliations: | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Virology Biology, Molecular BiologyGoogle:
"Stefan Duensing"Children
Sign in to add trainee| Nicole A. Spardy | grad student | 2009 | University of Pittsburgh |
| Nina M. Korzeniewski | grad student | 2010 | University of Pittsburgh |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Li J, Pohl L, Schüler J, et al. (2021) Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery. Biomedicines. 9 |
| Tapia-Laliena MÁ, Korzeniewski N, Peña-Llopis S, et al. (2019) Cullin 5 is a novel candidate tumor suppressor in renal cell carcinoma involved in the maintenance of genome stability. Oncogenesis. 8: 4 |
| Heller M, Prigge ES, Kaczorowski A, et al. (2017) APOBEC3A Expression in Penile Squamous Cell Carcinoma. Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology |
| Hoefflin R, Lahrmann B, Warsow G, et al. (2016) Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity. Nature Communications. 7: ncomms11845 |
| Mang J, Korzeniewski N, Dietrich D, et al. (2015) Prognostic Significance and Functional Role of CEP57 in Prostate Cancer. Translational Oncology. 8: 487-96 |
| Korzeniewski N, Tosev G, Pahernik S, et al. (2015) Identification of cell-free microRNAs in the urine of patients with prostate cancer. Urologic Oncology. 33: 16.e17-22 |
| Schneider M, Korzeniewski N, Merkle K, et al. (2015) The tyrosine kinase inhibitor nilotinib has antineoplastic activity in prostate cancer cells but up-regulates the ERK survival signal-Implications for targeted therapies. Urologic Oncology. 33: 72.e1-7 |
| Georgi B, Korzeniewski N, Hadaschik B, et al. (2014) Evolving therapeutic concepts in prostate cancer based on genome-wide analyses (review). International Journal of Oncology. 45: 1337-44 |
| Tapia-Laliena MA, Korzeniewski N, Hohenfellner M, et al. (2014) High-risk prostate cancer: a disease of genomic instability. Urologic Oncology. 32: 1101-7 |
| Schneider M, Schüler J, Höfflin R, et al. (2014) Phenotypic drug screening and target validation for improved personalized therapy reveal the complexity of phenotype-genotype correlations in clear cell renal cell carcinoma. Urologic Oncology. 32: 877-84 |